Atlanta, Georgia--(Newsfile Corp. - January 25, 2021) - Holzer & Holzer, LLC is investigating whether Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ: OCGN) complied with federal securities laws. On January 12, 2021, Ocugen announced the cancellation of a Company stockholder meeting for the following day and plans to re-evaluate the details of a proposed increase in the number of shares of common stock "in light of the recent potential addition of COVAXINT to its pipeline as well as its compliance with Nasdaq's Listing Rule 5550(a)(2)." The price of Ocugen's stock fell following the announcement.
If you purchased shares of Ocugen and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at email@example.com or Luke R. Kennedy, Esq. at firstname.lastname@example.org, or by toll-free telephone at (888) 508-6832 to discuss your legal rights or at www.holzerlaw.com.
Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.
Corey D. Holzer, Esq.
(888) 508-6832 (toll-free)
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/72773